Pharmacokinetics for the prescriber
Howard L McLeod PharmD is the Fred Eshelman Distinguished Professor of Pharmacy and Medicine and Director of the Institute for Pharmacogenomics and Individualized Therapy at the University of North Carolina, USA. He trained in Seattle, Philadelphia, Memphis, and Glasgow, UK. His research interests include the clinical pharmacology of anticancer drugs, the molecular basis of polymorphic drug metabolism, and the evaluation of cellular targets for chemotherapy within human tumours. Competing interests: none declared
PII: S1357-3039(08)00112-6
doi:10.1016/j.mpmed.2008.04.003
© 2008 Elsevier Ltd. All rights reserved.
http://s7.addthis.com/js/250/addthis_widget.js#pub=xa-4b1d65bd00983246Access this article on
SciVerse ScienceDirect
Visit SciVerse ScienceDirect to see if you have access via your institution.